A user discussed a case where an individual used PT-141 for libido enhancement while simultaneously withdrawing from benzodiazepines. The report suggests that the peptide was being evaluated for its effectiveness during a difficult physiological transition, though the overlapping effects of withdrawal made the results complex to interpret.